Fact checked byRichard Smith

Read more

November 06, 2022
3 min read
Save

Mindfulness may offer an ‘appealing approach’ to lower blood pressure

Fact checked byRichard Smith
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — A mindfulness-based program adapted for individuals with elevated BP showed “potentially clinically relevant” reductions in systolic BP 6 months after participation, researchers reported.

At 6 months’ follow-up, participants of the mindfulness-based program had a mean reduction in systolic BP of nearly 6 mm Hg, Eric B. Loucks, PhD, associate professor of epidemiology and director of the Mindfulness Center at Brown University, said during a presentation at the American Heart Association Scientific Sessions.

mindfulness
A mindfulness-based program adapted for individuals with elevated BP showed “potentially clinically relevant” reductions in systolic BP 6 months after participation.
Source: Adobe Stock

The Mindfulness-Based Blood Pressure Reduction (MB-BP) program focuses on training participants in skills such as attention control, self-awareness and emotion regulation. That training is then applied to health behavior change. This could be a novel strategy to improve BP control, according to Loucks.

Mindfulness training

Researchers recruited more than 200 adults from the Providence, Rhode Island, area who had elevated BP (> 120/80 mm Hg). Participants were mostly women (59%), the mean age was 59 years, 81% were white and 73% had a college education.

Half of participants were randomly assigned to enhanced usual care, which comprised a home BP monitor and training, BP education materials from the AHA and facilitated access to a physician, if needed. The other half were randomly assigned to the MB-BP program, which consisted of an in-person group orientation session, eight 2.5-hour weekly group sessions and a 7.5-hour group retreat. Participants were also recommended to follow a home mindfulness practice of at least 45 minutes per day 6 days per week.

“Mindfulness training trains us in attention control so that we can place our mind where we choose to place it, through practice on the breath or meditating on other parts of the body. ... There’s some self-awareness that arises in terms of how we feel the next day after a lot of alcohol consumption, for example, or a lack of physical activity or actually a good amount of physical activity ... [and] then you might get some insights that arise with the enhanced attention control [and] can act on it. That’s the framework we developed and are testing in this program,” Loucks said during a press conference.

Reduction in systolic BP

The primary outcome was change in unattended office systolic BP at 6 months.

Results showed a 5.9 mm Hg reduction in unattended office systolic BP at 6 months’ follow-up in the mindfulness-based program group compared with a 1.4 mm Hg reduction in the enhanced usual care group. The between-group difference was 4.5 mm Hg (P = .045), Loucks reported.

There were no notable changes in diastolic BP in either group.

The researchers then looked at examples of plausible mechanisms. Participants in the mindfulness-based program group were more likely to have a higher Dietary Approaches to Stop Hypertension (DASH) diet score, improved perceived stress and levels of mindfulness, less sedentary time and higher levels of physical activity.

Implications and future directions

Loucks noted several limitations of the current study, including its limited duration of follow-up and inclusion of mainly college-educated white adults, which limits the generalizability of the findings. He said the researchers recently received a grant to adapt MB-BP with the Mohegan Native American tribal nation.

“I’d like to see this [study] replicated by groups other than us ... and with longer follow-up time and more generalizable participant samples. If that were to happen and the results held, it could be an appealing approach to help control the blood pressure of about half of Americans who have hypertension, of which of them only about half are controlled,” Loucks said.

Loucks referenced data from the Blood Pressure Lowering Treatment Trialists’ Collaboration published in The Lancet in 2021. In the meta-analysis of nearly 345,000 participants, a 5 mm Hg reduction in systolic BP translated into a 10% reduction risk for major CV events.

“With our 5.9 mm Hg drop [in systolic BP] from baseline [and] between-group difference of 4.5 mm Hg, this could be clinically relevant,” Loucks said.

The researchers are evaluating three different primary outcomes. The other two will be in a paper submitted soon, Loucks said.

Reference: